Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 8Recruiting 5Active not recruiting 5Terminated 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 1132Neoplasms 986Carcinoma, Non-Small-Cell Lung 904Prostatic Neoplasms 596Neoplasm Metastasis 531Leukemia, Myeloid, Acute 514Colorectal Neoplasms 493Lung Neoplasms 490Melanoma 488Multiple Myeloma 478Pancreatic Neoplasms 387Lymphoma 370Ovarian Neoplasms 368Recurrence 365Lymphoma, Non-Hodgkin 348Leukemia 340Leukemia, Lymphocytic, Chronic, B-Cell 322Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Head and Neck Neoplasms 276Carcinoma, Renal Cell 276Brain Neoplasms 276Carcinoma, Hepatocellular 261Glioblastoma 251Myelodysplastic Syndromes 244Lymphoma, Large B-Cell, Diffuse 244Squamous Cell Carcinoma of Head and Neck 242Lymphoma, Follicular 236Colonic Neoplasms 214Stomach Neoplasms 200Rectal Neoplasms 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Giant Cell Tumor of Tendon Sheath × Clear all
NCT04938180 2024-05-24

A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients

AmMax Bio, Inc.

Phase 2 Terminated
4 enrolled 17 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT01804530 2018-08-02

Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors

Plexxikon

Phase 1 Terminated
59 enrolled

Giant Cell Tumor of Tendon Sheath

NCT02673736 2018-08-02

A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor

Plexxikon

Phase 1 Terminated
11 enrolled

Giant Cell Tumor of Tendon Sheath, Joint Diseases, Neoplasms, Synovitis, Synovitis, Pigmented Villonodular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡